Alcohol use significantly associated with mental illness symptoms in college women

RNAi therapeutic, vutrisiran is FDA approved for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTR) in adults and is sold under the brand name

Gilead and Kite an­nounced Tues­day it re­ceived FDA ap­proval to short­en its man­u­fac­tur­ing process for the cell ther­a­py Yescar­ta, a move ex­pect­ed to re­duce the